Product information
From Health Canada
Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.
Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.
Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.
- Natural Product Number (NPN):
- 80085749
- Market status:
- Marketed
- Licence Status:
- Active
- Brand name(s):
-
A. Vogel Eye Drops
;
A. Vogel Eye Drops 0.1% - Licence holder:
- Bioforce Canada Inc.
- Dosage Form:
- Eye drops
- Recommended route of administration:
-
Ophthalmic
Sub population (Sub Pop.) | Quantity (Qty) | Frequency (Freq.) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sub Pop. | Age | Min. | Max. | UoM Footnote1 Age | Qty | Min. | Max. | UoM Qty | Freq. | Min. | Max. | UoM Freq. |
Adults | 19 | year(s) | 1.0 | 2.0 | Quantity Unit TBA | 3 | 4 | daily | ||||
- Recommended use or purpose:
- Sodium hyaluronate helps relieve dry eyes (including symptoms of burning and grittiness).
- Risk Information:
- Cautions and Warnings
- For external use only. Use of this product by more than one person could spread infection. To avoid contamination do not touch the tip of the container to any surface. Discard bottle after 6 months. Keep out of the reach of children. If the solution changes colour or becomes cloudy, do not use. If you are experiencing a thick, white, yellow, or green discharge that forms a crust on the eyelid or have a serious underlying medical cause for the infection, consult a health care practitioner prior to use. If you frequently contract infections that don't clear up easily, do not use. Stop use and consult a health care practitioner if symptoms worsen or persist for more than 48 hours, if changes in vision occur or if you experience eye pain.
Medicinal ingredients | Quantity (Qty) | Extract | Potency |
---|---|---|---|
Euphrasia officinalis |
0.1 %
|
1
:
2.222
DHE: 0.045 mg Fresh |
|
Hyaluronic acid, sodium salt |
0.1 %
|
- List of non-medicinal ingredients:
-
- Borax
- Boric acid
- Purified water
- Sodium chloride
- Date of licensing:
- 2018-05-31
- Revised date of licence:
- 2019-03-24
Application information
Related information
Contact us
For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).